Eis Eczacıbaşı İlaç ve Sanayi A.Ş. (ECILC)
Market Open
15 Jun, 15:00
XIST XIST Primary ₺
83. 05
+3.15
+3.9424%
₺
74.69B Market Cap
9.39 P/E Ratio
1.18% Div Yield
647,653 Volume
0 Eps
₺ 79.9
Previous Close Want to track ECILC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | 0.72 |
| | | - | - |
| | | - | 0.15 |
| | | - | 1.11 |
| | | - | - |
| | | - | 0.04 |
| | | - | 0.11 |
| | | - | 0.05 |
| | | - | - |
| | | - | 0.09 |
| | | - | 0.03 |
| | | - | 0.05 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.01 |
| | | - | 0.02 |
| | | - | 0.04 |
| | | - | 0.03 |
| | | - | 0 |
| | | - | 0.06 |
ECILC Earnings Reports FAQ
What is the earnings per share (EPS) for ECILC?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 23.86%, reflecting the ECILC's performance and XIST market conditions.
When is the next earnings release date?
Eis Eczacıbaşı İlaç ve Sanayi A.Ş has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Eis Eczacıbaşı İlaç ve Sanayi A.Ş are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ECILC at this time, as Eis Eczacıbaşı İlaç ve Sanayi A.Ş has no recent EPS data to calculate it.
